Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
61,827,467
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
36,340,047
-
Shares change
-
+1,418,967
-
Total reported value, excl. options
-
$741,974,000
-
Value change
-
+$28,074,571
-
Number of buys
-
31
-
Number of sells
-
-20
-
Price
-
$20.42
Significant Holders of Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) as of Q4 2021
63 filings reported holding GLUE - Monte Rosa Therapeutics, Inc. - COMMON STOCK as of Q4 2021.
Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36,340,047 shares
of 61,827,467 outstanding shares and own 58.78% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (7,703,205 shares), FMR LLC (6,975,887 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,146,919 shares), Avoro Capital Advisors LLC (3,311,434 shares), Cormorant Asset Management, LP (3,002,199 shares), BlackRock Inc. (2,353,764 shares), Aisling Capital Management LP (1,472,331 shares), Alphabet Inc. (1,464,015 shares), RTW INVESTMENTS, LP (1,214,572 shares), and VANGUARD GROUP INC (1,080,616 shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.